Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Citations per year, relative to Finnegan Lp Finnegan Lp (= 1×)
peers
Tatiana M. Doberczak
Countries citing papers authored by Finnegan Lp
Since
Specialization
Citations
This map shows the geographic impact of Finnegan Lp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finnegan Lp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finnegan Lp more than expected).
This network shows the impact of papers produced by Finnegan Lp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finnegan Lp. The network helps show where Finnegan Lp may publish in the future.
Co-authorship network of co-authors of Finnegan Lp
This figure shows the co-authorship network connecting the top 25 collaborators of Finnegan Lp.
A scholar is included among the top collaborators of Finnegan Lp based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Finnegan Lp. Finnegan Lp is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
14 of 14 papers shown
1.
Kaltenbach, Karol & Finnegan Lp. (1987). Perinatal and developmental outcome of infants exposed to methadone in-utero.. PubMed. 76. 276–276.16 indexed citations
2.
Ehrlich, Saundra M., et al.. (1987). Cocaine abuse in pregnancy: effects on the fetus and newborn.. PubMed. 76. 280–280.1 indexed citations
3.
Wapner, Ronald J., et al.. (1987). Addiction in pregnancy: high risk intrapartum management and outcome.. PubMed. 7(3). 178–84.12 indexed citations
4.
Kaltenbach, Karol & Finnegan Lp. (1985). Developmental outcome of children born to methadone maintained women: a review of longitudinal studies.. PubMed. 6(4). 271–5.45 indexed citations
5.
Lp, Finnegan, et al.. (1984). The use of phenobarbital in treating abstinence in newborns exposed in utero to psychoactive agents.. PubMed. 49. 329–329.10 indexed citations
6.
Lp, Finnegan, et al.. (1984). Maternal drug use and the effectiveness of pharmacotherapy for neonatal abstinence.. PubMed. 55. 158–158.4 indexed citations
7.
Pasto, Matthew E., et al.. (1984). Cerebral ventricular changes in newborns exposed to psychoactive agents in utero.. PubMed. 49. 331–331.1 indexed citations
8.
Lp, Finnegan, et al.. (1984). Your CE topic this month (no. 3). Drug abuse in pregnancy.. PubMed. 34(2). 14–23.1 indexed citations
9.
Lp, Finnegan, et al.. (1983). Prevalence and implications of multi-drug abuse in a population of methadone-maintained women.. PubMed. 43. 322–8.4 indexed citations
10.
Lp, Finnegan, et al.. (1982). The effects of perinatal addiction on pulmonary function in the newborn.. PubMed. 41. 319–26.1 indexed citations
11.
Lp, Finnegan. (1980). Pathophysiological and behavioural effects of the transplacental transfer of narcotic drugs to the foetuses and neonates of narcotic-dependent mothers.. PubMed. 31(3-4). 1–58.32 indexed citations
12.
Lp, Finnegan, et al.. (1975). Current concepts in the management of the pregnant opiate addict.. PubMed. 2(1-2). 21–35.44 indexed citations
13.
Litt, Mitchell, et al.. (1975). Narcotic addiction in the newborn: differences in behavior generated by methadone and heroin.. PubMed. 12(1-2). 63–9.15 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.